Targeting Pediatric Brain Tumors With Sodium Glucose Cotransporter 2

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03068832` - Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors	Phase 1
Terminated	`NCT03330197` - A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG	Phase 1/Phase 2
Active, not recruiting	`NCT03911388` - HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors	Phase 1
Recruiting	`NCT05367076` - Fitness to Aid the Brain and Cognitive Skills	N/A
Completed	`NCT03615404` - Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma	Phase 1
Completed	`NCT04351035` - National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Registry
Completed	`NCT01707836` - Neurofibromatosis Type 1 Brain Tumor Genetic Risk	N/A
Withdrawn	`NCT03577600` - Compassionate Treatment in Children With Brain Tumors With the Cytotron®	N/A
Completed	`NCT04659421` - Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas	Phase 2
Active, not recruiting	`NCT03739372` - Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma	N/A
Recruiting	`NCT05887882` - Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors	Phase 1
Suspended	`NCT03334162` - Playful Sensorimotor Training in Pediatric Brain Tumor Patients	N/A
Withdrawn	`NCT01861990` - Valproic Acid in Childhood Progressive Brain Tumors	Phase 1
Recruiting	`NCT06226519` - Integrated PET/MRI and Germline Variants to Differentiate Brain Tumopr Recurrence From Iatrogenicchanges in Children
Completed	`NCT04944875` - Effects of Music and Maternal Voice on Sedation Depth and Sedative Use During Pediatric Magnetic Resonance Imaging.	N/A
Terminated	`NCT03591861` - Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis	N/A
Completed	`NCT03434262` - SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors	Phase 1
Recruiting	`NCT04239092` - 9-ING-41 in Pediatric Patients With Refractory Malignancies.	Phase 1
Active, not recruiting	`NCT03208387` - Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Recruiting	`NCT05528939` - Feasibility/Acceptability of Attentional-Control Training in Survivors	N/A

NCT number	NCT05521984
Study type	Interventional
Source	Washington University School of Medicine
Contact	Andrew Cluster, M.D.
Phone	314-273-1451
Email	acluster@wustl.edu
Status	Recruiting
Phase	Phase 1
Start date	April 3, 2023
Completion date	November 30, 2026

Targeting Pediatric Brain Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms